Charles A. Cancer Center, Baylor University Medical Center

Dallas, Texas 75246

0 studies enrolling now · 1 studies all time

What they study most

Chronic Graft-versus-host Disease

Studies at this site

• Bortezomib for the Treatment of Refractory Chronic Graft-vs-Host Disease(cGVHD) — Status unconfirmed